This model provides detailed sales and volume forecast data for the inflammatory bowel disease market. Including Crohn’s disease and ulcerative colitis market sizing, within the context of total brand sales across the seven major markets.
Reasons to Purchase
*Quantify the current size of IBD sales in the seven major markets and understand trends in the rest of the world
*Understand IBD market trends and assess the impact of events, such as biosimilars entry, on sales of over 30 key brand name products
*Access a case study assessing the likelihood of ulcerative colitis approval for Humira and Simponi with three alternative scenario forecasts
#N/A
Other selected research from the 'Gastroenterology' category:
Inflammatory Bowel Disease: World Market 2010-2025
Our new report examines current and future prospects for the inflammatory bowel disease (IBD) drug market. The global market for IBD drugs exceeded $5bn in 2009, with strong growth from... Learn More
Inflammatory Bowel Disease Market Forecast
The inflammatory bowel disease market is set to grow from $2.9 billion in 2008 to $4.5 billion in 2018 across the seven major markets. Learn More